Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

25.80 +0.61 (+2.40%)

Streaming Delayed Price Updated: 1:59 PM EDT, May 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

Today 12:00 EDT

From Hims & Hers

Via Business Wire

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

May 21, 2026

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Government

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

May 21, 2026

From Hims & Hers

Via Business Wire

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

May 21, 2026

Analysts project billions in future market value as biotech innovation and consumer demand continue driving the next wave of health performance products

From MarketNewsUpdates.com

Via GlobeNewswire

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

May 18, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

May 18, 2026

From Hims & Hers

Via Business Wire

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

May 12, 2026

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

May 12, 2026

Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors

From MarketNewsUpdates.com

Via GlobeNewswire

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

May 11, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors

April 28, 2026

From Hims & Hers

Via Business Wire

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

April 13, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

April 03, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

April 01, 2026

From Schall Law

Via GlobeNewswire

Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers

March 26, 2026

From Hims & Hers

Via Business Wire

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

March 25, 2026

From Schall Law

Via GlobeNewswire

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

March 10, 2026

From Hims & Hers

Via Business Wire

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

March 10, 2026

From Hims & Hers

Via Business Wire

ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!

March 09, 2026

Via AB Newswire

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

March 09, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Hims & Hers Announces Strategic Shift for US Weight Loss Business

March 09, 2026

From Hims & Hers

Via Business Wire

Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

March 02, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

February 27, 2026

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

February 25, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

February 23, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

February 19, 2026

From Hims & Hers

Via Business Wire

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

February 18, 2026

From Schall Law

Via GlobeNewswire

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

February 09, 2026

From The Schall Law Firm

Via Business Wire

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

February 05, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

February 04, 2026

From Hims & Hers

Via Business Wire

Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

February 02, 2026

From Hims & Hers

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.